DSM Venturing

DSM Venturing is the corporate venture capital arm of Royal DSM, established in 2001 and headquartered in Heerlen, Netherlands. The firm focuses on investing in start-up companies that develop innovative products and services within the life sciences sector, which encompasses both animal and human health and nutrition. Over the years, DSM Venturing has invested in more than fifty emerging companies across the United States, Europe, and Israel. Its primary objective is to generate strategic options and enhance value for DSM and its broader ecosystem while achieving sustainable venture-grade investment returns.

Rob Beudeker

Investment Director

Scott Horner

Regional Managing Director North America

Greg McParland

Investment Director

Arpesh Mehta

Investment Director

Erik Rutten

Senior Investment Manager

Past deals in New Brunswick

Natreon

Venture Round in 2015
Natreon, Inc. is a New Jersey-based company specializing in the development and marketing of Ayurvedic products. Founded in 1998, it operates a state-of-the-art research and development facility in Kolkata, India. Natreon focuses on creating dietary supplements derived from traditional Ayurvedic ingredients, with products such as CAPROS, an all-natural antioxidant for cardiovascular health; SENSORIL, an Ashwagandha formulation aimed at reducing stress and enhancing cognition; AYUFLEX, designed for joint health; and PRIMAVIE, a mitochondrial energy booster. The company emphasizes rigorous research and has established multiple clinical and safety studies to support its product efficacy. Natreon holds patents for its offerings in the United States and internationally, reinforcing its commitment to high standards and innovation in the wellness sector.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.